Vaxfab enterprises Limited has completed a significant equity allotment through warrant conversion, strengthening its capital base. The Board of Directors approved the allotment of 26,86,268 equity shares at its meeting held on 13th February, 2026, marking an important milestone in the company's capital structure expansion.

Allotment Details and Pricing Structure

The company allotted equity shares of face value Rs. 10 each at a price of Rs. 21.02 per share through warrant conversion on a preferential basis. The warrant holders had initially paid Rs. 5.255 at the time of warrant allotment and paid the remaining Rs. 15.765 at the time of conversion into equity shares.

Impact on Share Capital

Following this allotment, the company's paid-up equity share capital has increased substantially. The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company.

Investor Participation and Conversion Details

The warrant conversion involved 12 investors with varying levels of participation. Major conversions included Balmukund Tradelink Private Limited converting 805,582 warrants for Rs. 12,700,000, and Markand Tradeventure LLP converting 634,317 warrants for Rs. 10,000,000.

Notable individual participants included:

• Ashish Lakhiram Agrawal: Converted all 142,721 warrants
• Vipul Patel: Converted 31,717 out of originally allotted 47,574 warrants
• Gohel Falgunkumar Dhanjibhai: Converted 150,650 warrants for Rs. 2,375,000

Regulatory Compliance and Documentation

The allotment was conducted in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 1:00 PM and concluded at 1:20 PM on 13th February, 2026, with proper documentation submitted to BSE Limited and The Calcutta Stock Exchange Limited.

The company has fulfilled all disclosure requirements under SEBI LODR regulations, ensuring transparency in the warrant conversion process and maintaining regulatory compliance throughout the allotment procedure.

Vaxfab enterprises Limited has successfully completed the allotment of 2,22,011 equity shares through warrant conversion, as announced by the company's board of directors on February 2, 2026. The allotment represents a significant capital raising exercise that has expanded the company's equity base.

Allotment Details

The board meeting, held on February 2, 2026, approved the allotment of equity shares with a face value of Rs. 10 each at a price of Rs. 21.02 per share. These shares were issued upon conversion of warrants into fully paid-up equity shares on a preferential basis to three investors.

Impact on Share Capital

Following the warrant conversion, the company's paid-up equity share capital has increased substantially. The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company, ensuring equal rights and privileges for all shareholders.

Warrant Conversion Details

The warrant conversion process involved a two-stage payment mechanism. Initially, warrant holders paid Rs. 5.255 per warrant at the time of allotment, followed by Rs. 15.765 per warrant at the time of conversion into equity shares, totaling Rs. 21.02 per share.

Investor-wise Conversion

The conversion process shows that while two HUF entities completely converted their warrant holdings, Kushmanda Tradeline LLP exercised only a portion of its warrants, retaining 9,19,760 warrants for potential future conversion. The warrants had a tenure not exceeding 18 months from the date of original allotment.

Regulatory Compliance

The allotment was conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 6.00 P.M. and concluded at 6.30 P.M. on February 2, 2026, with all necessary approvals obtained for the warrant conversion process.